ArticleJournal for immunotherapy of cancer2026

YMN-V115: a novel humanized BCMA/GPRC5D/CD3 trispecific antibody in relapsed/refractory multiple myeloma.

Jia Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.